Systemic Autoimmune Diseases

1990.- Licenciado en Medicina, Universidad Autónoma de Madrid, 1999.- Doctor en Medicina, Universidad del País Vasco 1996.- Especialista en Medicina Interna 1991-1995.- Residente de Medicina Interna, HU Cruces 1994 & 1999-2000.- Research Fellow, Lupus Research Unit, St. Thomas' Hospital, UK 1997-2001.- Facultativo Especialista en Medicina Interna, Hospital de Mendaro 2001-2010 - Facultativo Especialista en Medicina Interna, HU Cruces 2010.- Jefe de Sección de Enfermedades Autoinmnes, HU Cruces 2004.- Profesor Titular de Medicina, Universidad del País Vasco 217 publicaciones indexadas. Areas principales de investigación: lupus eritematoso sistémico, síndrome antifosfolípido, enfermedades autoinmunes y embarazo. Miembro de SLICC (Systemic Lupus Collaborating Clinics). Miembro del Grupo de Estudio de Enfermedades Autoinmunes Sistémicas (GEAS). Coordinador del Area de Enfermedades Autoinmunes, Inflamatorias e Infecciosas BioCruces Bizkaia.

Christophe Richez, MD, PhD, works in the Rheumatology Department at Hôpital Pellegrin and is affiliated with the Immuno ConcEpT Lab CNRS UMR 5164 at the University of Bordeaux, Bordeaux, France. He is Head of the National Reference Center RESO for rare autoimmune systemic diseases, and the Club Rhumatismes et Inflammation. His main research interests are translational research on the role of different actors, such as selectins, Tfh, Tph and others, in the pathogenesis of systemic lupus erythematosus. His clinical research focuses on treatment strategy in rheumatoid arthritis (RA), notably with 2 ongoing clinical trials on combination of metformine and methotrexate in early RA, and combination of baricitinib and adalimumab in refractory RA. Professor Richez is a member of the scientific committee of major French rheumatology societies including the Société Française de Rhumatologie, FAI2R, GR2, and Fondation Arthritis. He is also member of the steering committee of the ERN ReCONNET.